Schedule by Topic

Pre-Conference Wednesday October 21

Pre-Conference

Impact of Ethnicity and Race in Cardiometabolic Health:

Implications for Risk Assessment and Management

FDA Update and Keynote Thursday October 22

 

FDA Update and Keynote

Session II Thursday October 22

Session I

Hypertension / Heart Failure / Kidney

Session II Friday October 23

Session II

Dyslipidemia / Atherosclerosis / Thrombosis

Session III Friday October 23

Session III

Diabetes

Session IV Saturday October 24

Session IV

Obesity & Lifestyle

Wednesday, October 21

Pre-Conference

Impact of Ethnicity and Race in Cardiometabolic Health:
Implications for Risk Assessment and Management

12:00 - 1:00 PM

Virtual PME Symposium (Non-CME)

The Interconnected Cardio-Renal-Metabolic (CRM) Systems

Eden Miller, DO; Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.

1:00 - 1:15 PM

Active Stretch Session with NASM-Certified Fitness Instructor Aria Aloi

1:15 - 1:15 PM

Opening Remarks

Keith C. Ferdinand, MD (Chair)

1:15 - 1:35 PM

The Role of Racial, Ethnic, and Social Factors in Cardiometabolic Health: An Overview

Keith C. Ferdinand, MD

1:35 - 1:55 PM

Managing T2D in the Hispanic/Latino Population

A. Enrique Caballero, MD

1:55 - 2:15 PM

A Polypill for Prevention of Cardiovascular Disease in Racial Minorities: Can We Bridge the Gap?

Daniel Muñoz, MD, MPA

2:15 - 2:45 PM

Evolving Treatment Paradigms, New Therapies, New Guidelines, But at What Cost?

Deirdre J. Mattina, MD

2:45 - 3:15 PM

Expert Panel Discussion and Audience Q & A

Chair: Keith C. Ferdinand, MD
Panel:A. Enrique Caballero, MD; Karol Harshaw-Ellis,DNP; Deirdre J. Mattina, MD; Daniel Muñoz, MD, MPA

3:15 - 3:45 PM

Company Spotlight Break

3:45 - 4:45 PM

Primetime CME Symposium
ABC Access To Care Initiative: Overcoming Disparities and Gaps in the Diagnosis and Treatment of Familial Hypercholesterolemia
Multisupported by educational grants from Esperion Therapeutics, Inc. and Novartis Pharmaceuticals Corporation and in partnership with the Association of Black Cardiologists, Inc (ABC) and the FH Foundation.
Chair: Keith C. Ferdinand, MD
Faculty: Christie M. Ballantyne, MD; Stephen L. Kopecky, MD
Patient Advocate: Chad Gradney

4:45 - 5:05 PM

Do Diabetes Cardiovascular Outcomes Trials Have a Minority Problem?

Leonor Corsino, MD

5:05 - 5:25 PM

The Racial and Ethnic Differences in Cardiometabolic Risk Factors and What They Mean for Your Practice

Carlos J. Rodriguez, MD

5:25 - 5:45 PM

How Should You Counsel Patients Who Live in Food Deserts?

Alanna A. Morris, MD

5:45 - 6:15 PM

Expert Panel Discussion and Audience Q & A

Chair: Keith C. Ferdinand, MD
Panel: Leonor Corsino, MD; Karol Harshaw-Ellis,DNP; Alanna A. Morris, MD, MSc; Carlos J. Rodriguez, MD

6:15 - 6:30 PM

Refresh and Recharge Break

6:30 - 7:30 PM

Virtual PME Symposium (Non-CME)

An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C

Eliot A. Brinton, MD, FAHA, FNLA, FACE

Sponsored by Esperion Therapeutics.

Thursday, October 22

Friday, October 23

Saturday, October 24

Session IV: Obesity & Lifestyle

8:15 AM

Opening Remarks

Robert H. Eckel, MD

8:15 - 8:35 AM

Physical Activity and Obesity Management

Holly R. Wyatt, MD

8:35 - 9:05 AM

Nutrition and Cardiometabolic Disorders Management

Alice H. Lichtenstein, D.Sc.

9:05 - 9:45 AM

NAFLD/NASH and the Continuum of Cardiometabolic Risk: Implications for Diagnosis & Management
Christos S. Mantzoros, MD, DSc

9:45 - 10:15 AM

Company Spotlight Break

10:15 - 10:35 AM

What BMI Should Be Used for Metabolic Surgery?

Supported by an educational grant from Medtronic.

David E. Cummings, MD

10:35 - 11:05 AM

Behavioral Strategies in Obesity Management

Louis J. Aronne, MD

11:05 - 11:25 AM

Obesity Paradox in Cardiovascular Disease - Is it Real?

Carl J. Lavie, MD

11:25 - 11:55 aM

Expert Panel Discussion

Chair: Robert H. Eckel, MD
Panel: Louis J. Aronne, MD; David E. Cummings, MD; Carl J. Lavie, MD; Alice H. Lichtenstein, D.Sc.; Holly R. Wyatt, MD

FDA Update and Keynote

7:00 - 8:00 AM

Sunrise CME Symposium
Preventing Adverse Cardiovascular and Limb Events in High-Risk Cardiometabolic Patients with Peripheral Artery Disease: Recent Trials and Advances

Chair: Marc P. Bonaca, MD

Faculty: Deepak L. Bhatt, MD, MPH; Manesh R. Patel, MD

Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

8:00 - 8:15 AM

Refresh and Recharge Break

8:15 - 9:45 AM

Opening Remarks & FDA Update and Late Breaking Trials

Chair: Christie M. Ballantyne, MD
Panel: Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Anne L. Peters

9:45 - 10:15 AM

Keynote
Evolving Paradigms in Cardiovascular Research and Care: Reflections and Perspectives

Eugene BraunwaldEugene Braunwald, MD

10:15 - 10:45 AM

Company Spotlight Break

10:45 - 11:45 AM

Primetime CME Symposium
The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients: Advances and Opportunities
Supported by an educational grant from Relypsa, Inc.

Chair: Matthew R. Weir, MD
Faculty: Javed Butler, MD, MPH, MBA; Ileana L. Piña, MD

SESSION I: Hypertension/Heart Failure/Kidney

11:45 - 11:50 AM

Opening Remarks

George L. Bakris, MD

11:50 AM - 12:10 PM

Understanding How to Interpret Signals from the Kidney When BP is Rapidly Controlled

George L. Bakris, MD

12:10 - 12:25 PM

Refresh and Recharge Break

12:25 - 1:25 PM

Virtual PME Symposium (Non-CME)

Atherosclerotic Cardiovascular Disease (ASCVD) in Diabetes: Identifying High Risk and the Importance of Reducing the Burden of Elevated LDL-C Levels

Yehuda Handelsman, MD

Sponsored by Novartis

1:25 - 1:40 PM

Active Stretch Session with NASM-Certified Fitness Instructor Aria Aloi

1:40 - 2:00 PM

Sleep and Blood Pressure Control: Implications for Hypertension

Virend K. Somers, MD, PhD

2:00 - 2:20 PM

From Bench to Bedside: Understanding Kidney Signals in the Setting of a Failing Heart

John C. Burnett Jr., MD

2:20 - 2:50 PM

Company Spotlight Break

2:50 - 3:50 PM

Primetime CME Symposium

Tackling Diabetic Kidney Disease Progression: Challenges, Advances, and Novel Approaches

Chair: George L. Bakris, MD

Faculty: Rajiv Agarwal, MD; Janet B. McGill, MD

Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

3:50 - 4:20 PM

Transthyretin Cardiac Amyloidosis: An Underestimated Cause of HF

Clyde W. Yancy, MD, MSc, MACP

4:20 - 5:05 PM

Challenging Cardio-Renal Cases & Panel Discussion

Chair: George L. Bakris, MD
Panel: John C. Burnett Jr., MD; Virend K. Somers, MD, PhD; Clyde W. Yancy, MD, MSc, MACP

5:05 - 5:20 PM

Refresh and Recharge Break

5:20 - 6:20 PM

Virtual PME Symposium (non-CME)

VASCEPA® (icosapent ethyl): Elevating the Standard of Care

Matthew Budoff, MD, FACC, FAHA

Sponsored by Amarin Pharma, Inc.

Session II: Dyslipidemia/Atherosclerosis/Thrombosis

8:15 AM

Opening Remarks

Christie M. Ballantyne, MD

8:15 - 8:45 AM

Beyond LDL: Targeting Inflammation to Reduce Cardiovascular Risk - Can Targeted Anti-Cytokine Therapy Prolong Life?

Paul M. Ridker, MD

8:45 - 9:45 AM

Primetime CME Symposium
The Evolving Landscape of LDL-C Reduction: Novel Therapies and Approaches
Supported by an educational grant from Esperion Therapeutics, Inc
Chair: Christie M. Ballantyne, MD
Faculty: Pam R. Taub, MD; Salim S. Virani, MD, PhD, FACC, FAHA

9:45 - 10:15 AM

Company Spotlight Break

10:15 - 10:45 AM

How Should High Lp(a) Levels Be Addressed?

Patrick M. Moriarty, MD

10:45 - 11:45 AM

Challenging Lipid Management Cases & Panel Discussion

Chair: Christie M. Ballantyne, MD
Panel: Patrick M. Moriarty, MD; Pamela B. Morris, MD; Paul M. Ridker, MD

11:45 AM - 12:00 PM

Refresh and Recharge

12:00 - 1:00 PM

Virtual PME Symposium (non-CME)

Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes

John E. Anderson, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

1:00 - 1:15 PM

Active Stretch Session with NASM-Certified Fitness Instructor Aria Aloi

Session III: Diabetes

1:15 - 1:20 PM

Opening Remarks

Anne L. Peters, MD

1:20 - 1:50 PM

Insulin Resistance: A 2020 Update

C. Ronald Kahn, MD

1:50 - 2:50 PM

Primetime CME Symposium
Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments
Supported by an educational grant from AstraZeneca
Chair: Deepak L. Bhatt, MD, MPH
Faculty: Lawrence A. Leiter MD; P. Gabriel Steg, MD

2:50 - 3:20 PM

Emerging Targets in Diabetes Treatment: What Dual Agent Should Be Developed?

Kathleen M. Dungan, MD, MPH

3:20 - 3:50 PM

Company Spotlight Break

3:50 - 4:20 PM

Expert Perspective: Disparities in Diabetes Guidelines

Athena Philis-Tsimikas, MD

4:20 - 5:20 PM

Multi-disciplinary Cases in T2D and Expert Panel Discussion

Chair: Anne L. Peters, MD
Panel: Kathleen M. Dungan, MD, MPH; Robert H. Eckel, MD; C. Ronald Kahn, MD; Athena Philis-Tsimikas, MD

5:20 - 5:25 PM

Refresh and Recharge Break

5:25 - 6:25 PM

Primetime CME Symposium
Optimizing Postprandial Glucose Control in Patients with Diabetes: Clinical Advances and Strategies
Supported by an educational grant from Dexcom, Inc. and Medtronic
Chair: Anne L. Peters, MD
Faculty: Irl B. Hirsch, MD Athena Philis-Tsimikas, MD